NexImmune Competitors and Similar CompaniesClear all
NexImmune's competitors and similar companies include Lantern Pharma and Dare Bioscience.
 NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform. |  Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 2013 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Gaithersburg, US HQ | Locations Dallas, US HQ | Locations San Diego, US HQ |
Employees | Employees 5032% decrease | Employees 241100% increase | Employees 980% increase |
Valuation ($) | Valuation ($) 372.4 k | Valuation ($) 37.6 m | Valuation ($) 33.8 m |
Financial | |||
Cost of goods | Cost of goods N/A | Cost of goods $7.4m (FY, 2025) | Cost of goods $295.8k (FY, 2025) |
Net income | Net income ($32.3m) (FY, 2023) | Net income ($17.1m) (FY, 2025) | Net income ($13.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 33.8m | Total funding raised $ 4.7m | Total funding raised $ 115.7m |
For sources of this data, please see the company profile
View Company Profiles
Lantern Pharma
HQ
Dallas, US
Employees
24
Lantern Pharma is a biotechnology company developing precision cancer drugs.
View companyDare Bioscience
HQ
San Diego, US
Employees
9
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View company